{"nct_id":"NCT01327612","title":"Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2011-03-03","start_date_type":"ACTUAL","primary_completion_date":"2020-02-05","primary_completion_date_type":"ACTUAL","completion_date":"2020-02-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}